These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3381889

  • 1. Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney.
    Klotzbach JM, Diamond GL.
    Am J Physiol; 1988 Jun; 254(6 Pt 2):F871-8. PubMed ID: 3381889
    [Abstract] [Full Text] [Related]

  • 2. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
    Diamond GL, Klotzbach JM, Stewart JR.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renal tubular secretion of the alkanesulfonate 2,3-dimercapto-1-propanesulfonate.
    Stewart JR, Diamond GL.
    Am J Physiol; 1987 May; 252(5 Pt 2):F800-10. PubMed ID: 3034073
    [Abstract] [Full Text] [Related]

  • 5. Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules.
    Lungkaphin A, Chatsudthipong V, Evans KK, Groves CE, Wright SH, Dantzler WH.
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F68-76. PubMed ID: 13129851
    [Abstract] [Full Text] [Related]

  • 6. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.
    Cherian MG, Miles EF, Clarkson TW, Cox C.
    J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of action of 2,3-dimercaptopropane-1-sulfonate and the transport, disposition, and toxicity of inorganic mercury in isolated perfused segments of rabbit proximal tubules.
    Zalups RK, Parks LD, Cannon VT, Barfuss DW.
    Mol Pharmacol; 1998 Aug; 54(2):353-63. PubMed ID: 9687577
    [Abstract] [Full Text] [Related]

  • 10. Excretion of para-aminohippurate in the isolated perfused rat kidney: net secretion and net reabsorption.
    MacDougall ML, Wiegmann TB.
    J Physiol; 1988 Mar; 397():459-69. PubMed ID: 3411514
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
    Zalups RK, Bridges CC.
    Chem Res Toxicol; 2012 Sep 17; 25(9):1825-38. PubMed ID: 22667351
    [Abstract] [Full Text] [Related]

  • 13. Organic anion transporter 3 (OAT3) and renal transport of the metal chelator 2,3-dimercapto-1-propanesulfonic acid (DMPS).
    Rödiger M, Zhang X, Ugele B, Gersdorff N, Wright SH, Burckhardt G, Bahn A.
    Can J Physiol Pharmacol; 2010 Feb 17; 88(2):141-6. PubMed ID: 20237588
    [Abstract] [Full Text] [Related]

  • 14. Interaction of the metal chelator 2,3-dimercapto-1-propanesulfonate with the rabbit multispecific organic anion transporter 1 (rbOAT1).
    Bahn A, Knabe M, Hagos Y, Rödiger M, Godehardt S, Graber-Neufeld DS, Evans KK, Burckhardt G, Wright SH.
    Mol Pharmacol; 2002 Nov 17; 62(5):1128-36. PubMed ID: 12391276
    [Abstract] [Full Text] [Related]

  • 15. Note on the metabolism of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate.
    Gabard B, Walser R.
    J Toxicol Environ Health; 1979 Jul 17; 5(4):759-64. PubMed ID: 490684
    [Abstract] [Full Text] [Related]

  • 16. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
    Maiorino RM, Dart RC, Carter DE, Aposhian HV.
    J Pharmacol Exp Ther; 1991 Nov 17; 259(2):808-14. PubMed ID: 1941628
    [Abstract] [Full Text] [Related]

  • 17. Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.
    Hurlbut KM, Maiorino RM, Mayersohn M, Dart RC, Bruce DC, Aposhian HV.
    J Pharmacol Exp Ther; 1994 Feb 17; 268(2):662-8. PubMed ID: 8113976
    [Abstract] [Full Text] [Related]

  • 18. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age.
    Kostial K, Kargacin B, Blanusa M, Landeka M.
    Arch Toxicol; 1984 Oct 17; 55(4):250-2. PubMed ID: 6517703
    [Abstract] [Full Text] [Related]

  • 19. [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
    Zhao-Fa X, Jing-Hua Y, Jia-Ming Y, Zhong-Wei Y.
    Wei Sheng Yan Jiu; 2005 Sep 17; 34(5):533-6. PubMed ID: 16329589
    [Abstract] [Full Text] [Related]

  • 20. Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transport.
    Wildenauer DB, Reuther H, Weger N.
    Chem Biol Interact; 1982 Nov 17; 42(2):165-77. PubMed ID: 7151227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.